Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0001562180-25-000956

Options or other derivatives

  • President, CMO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Huang Jane President, CMO 2025-02-04 Grant or award · Employee Stock Option (right to buy) +200,000 200,000 D: show line 1 in the form
Loading xslF345X05/primarydocument.xml…